PureTech Health plc

BATS-CHIXE:PRTCL Stock Report

Market Cap: UK£370.6m

PureTech Health Management

Management criteria checks 1/4

PureTech Health's CEO is Bharatt Chowrira, appointed in Apr 2024, has a tenure of less than a year. total yearly compensation is $2.49M, comprised of 23.1% salary and 76.9% bonuses, including company stock and options. directly owns 0.42% of the company’s shares, worth £1.56M. The average tenure of the management team and the board of directors is 0.8 years and 8.2 years respectively.

Key information

Bharatt Chowrira

Chief executive officer

US$2.5m

Total compensation

CEO salary percentage23.1%
CEO tenureless than a year
CEO ownership0.4%
Management average tenureless than a year
Board average tenure8.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bharatt Chowrira's remuneration changed compared to PureTech Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$82m

Mar 31 2024n/an/a

-US$74m

Dec 31 2023US$2mUS$575k

-US$66m

Sep 30 2023n/an/a

-US$56m

Jun 30 2023n/an/a

-US$47m

Mar 31 2023n/an/a

-US$49m

Dec 31 2022US$988kUS$530k

-US$50m

Sep 30 2022n/an/a

-US$32m

Jun 30 2022n/an/a

-US$14m

Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$1mUS$500k

-US$61m

Compensation vs Market: Bharatt's total compensation ($USD2.49M) is above average for companies of similar size in the UK market ($USD962.59K).

Compensation vs Earnings: Bharatt's compensation has increased whilst the company is unprofitable.

CEO

Bharatt Chowrira (59 yo)

less than a year

Tenure

US$2,490,425

Compensation

Dr. Bharatt M. Chowrira, J. D. Ph. D. served as Chief Business and Operating Officer at PureTech Health plc. since January 2022 until 2024 and serves as its Chief Executive Officer from April 09, 2024 and...

Leadership Team

NamePositionTenureCompensationOwnership
Bharatt Chowrira
CEO & Executive Directorless than a yearUS$2.49m0.42%
£ 1.6m
Daphne Zohar
Founderno dataUS$4.74m3.35%
£ 12.4m
Robert S. Langer
Co-Founder & Non-Executive Directorno dataUS$135.00k1.15%
£ 4.3m
Eric Elenko
Co-Founder & Presidentless than a yearno datano data
David Elmaleh
Co-Founder & Senior Advisorno datano datano data
Lauren White
Chief Financial Officerless than a yearno datano data
Eric Green
Chief Operating Officerless than a yearno datano data
Allison Talbot
Head of Communications & Investor Relationsno datano datano data
Charles Sherwood
General Counsel & Company Secretaryless than a yearno datano data
Spencer Ball
Senior Vice President of Human Resources4.4yrsno datano data
Aleksandra Filipovic
Head of Oncology4.4yrsno datano data
Cheryl Murphy
Head of Grants Management & Strategy4.4yrsno datano data

0.8yrs

Average Tenure

56yo

Average Age

Experienced Management: PRTCL's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Bharatt Chowrira
CEO & Executive Director3.8yrsUS$2.49m0.42%
£ 1.6m
Daphne Zohar
Founderless than a yearUS$4.74m3.35%
£ 12.4m
Robert S. Langer
Co-Founder & Non-Executive Directorno dataUS$135.00k1.15%
£ 4.3m
David Elmaleh
Co-Founder & Senior Advisorno datano datano data
Raju Kucherlapati
Chair & Senior Independent Director10.9yrsUS$172.50k1.05%
£ 3.9m
John LaMattina
Independent Non-Executive Director15.9yrsUS$137.75k0.63%
£ 2.3m
Bennett Shapiro
Board Advisor4.5yrsUS$68.94kno data
R. Anderson
Advisor8.2yrsno datano data
James Collins
Advisor9.1yrsno datano data
Donald Ingber
Senior Advisor8.9yrsno datano data
Frederick Frank
Senior Advisorno datano datano data
Sharon Barber-Lui
Independent Non-Executive Director2.8yrsUS$135.00k0.016%
£ 59.8k

8.2yrs

Average Tenure

74yo

Average Age

Experienced Board: PRTCL's board of directors are considered experienced (8.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 05:11
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PureTech Health plc is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter WelfordJefferies LLC
Thomas SmithLeerink Partners LLC
Faisal KhurshidLeerink Partners LLC